Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0327492 ANTI-CD79b ANTIBODIES AND METHODS OF USE
The invention provides anti-CD79b antibodies and methods of using the same.
2018/0327491 IMPROVED P2X7 RECEPTOR BINDERS AND POLYPEPTIDES COMPRISING THE SAME
The present invention relates to amino acid sequences and polypeptides binding to the P2X7 receptor. In particular, the present invention relates to improved...
2018/0327490 METHODS FOR TREATING CROHN'S DISEASE USING AN ANTI-IL23 ANTIBODY
The invention relates to products and methods for treating Crohn's disease. The products relate to antibodies that inhibit native human IL-23 while sparing...
2018/0327489 THYMIC STROMAL LYMPHOPOIETIN (TSLP)-BINDING MOLECULES AND METHODS OF USING THE MOLECULES
The invention provides molecules, e.g., antibodies or antibody fragments, that specifically bind thymic stromal lymphopoietin (TSLP), compositions comprising...
2018/0327488 ANTI AMPHIREGULIN ANTIBODIES, COMPOSITIONS COMPRISING SAME AND USES THEREOF
A method of determining the suitability of a subject to a treatment with an anti-amphiregulin antibody, wherein the subject has a cancer selected from the...
2018/0327487 GARP-TGF-BETA ANTIBODIES
The present invention relates to antibodies and antigen binding fragments thereof, which bind to a complex of GARP and TGF-.beta.1, particularly a complex of...
2018/0327486 COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING FACTOR P
The present invention relates to antibodies or antigen binding fragments thereof that bind to complement Factor P and used thereof as well as combinations of...
2018/0327485 HUMANIZED ANTIBODY
The present invention is related to chimeric and humanized antibody and to methods and compositions for the therapeutic and diagnostic use in the treatment of...
2018/0327484 RSV-SPECIFIC BINDING MOLECULES AND MEANS FOR PRODUCING THEM
The invention provides antibodies and functional equivalents thereof which are capable of specifically binding RSV, and means and methods for producing them.
2018/0327483 MONOCLONAL ANTIBODIES SPECIFICALLY FOR THE ANTIGEN P OF THE HUMAN RESPIRATORY SYNCYTIAL VIRUS, PRODUCED AND...
The present invention refers to monoclonal antibodies or fragments thereof which are binding to the protein P of the human Respiratory Syncytial Virus (RSV)...
2018/0327482 METHODS AND COMPOSITIONS FOR THE TREATMENT OF HCMV
Provided herein are compositions and methods for the treatment of HCMV infection in a subject.
2018/0327481 Synthetic Single Domain Antibody
The invention relates to the identification of a highly stable single domain antibody scaffold (hs2dAb) and its use in generating synthetic single domain...
2018/0327480 Phage Display Vectors and Methods of Use
The present invention relates to vectors suitable for use in displaying proteins on the surface of bacteriophage M13 as fusion constructs with the surface...
2018/0327479 Factor VIII Variants Having A Decreased Cellular Uptake
The present invention relates to modified coagulation factors. In particular, the present invention relates to modied Factor VIII molecules having decreased...
2018/0327478 METHOD FOR THE PRODUCTION OF FREEZE-DRIED PELLETS COMPRISING FACTOR VIII
A method for the production of freeze-dried pellets comprising factor VIII comprises the steps of: a) freezing droplets of a solution comprising factor VIII to...
2018/0327477 TGF-BETA RECEPTOR TYPE II FUSION PROTEINS AND USES THEREOF
In certain aspects, the present disclosure relates to T.beta.RII fusion polypeptides comprising a heterologous portion and a truncated, ligand-binding portion...
2018/0327476 CHIMERIC POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, CELLS EXPRESSING SAME AND METHODS OF PRODUCING SAME
A plant produced chimeric polypeptide is provided. The plant produced chimeric polypeptide comprising: (i) a first domain which comprises a TNF Alpha binding...
2018/0327475 NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates...
2018/0327474 NOVEL PEPTIDES, COMBINATION OF PEPTIDES AS TARGETS AND FOR USE IN IMMUNOTHERAPY AGAINST GALLBLADDER CANCER AND...
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates...
2018/0327473 Human Alpha Fetoprotein-Specific Murine T Cell Receptors and Uses Thereof
T cell receptors that specifically recognize hAFP.sub.158 and methods of their use are provided.
2018/0327472 FORMULATION OF MODIFIED INTERLEUKIN-7 FUSION PROTEIN
Provided is a pharmaceutical formulation comprising a modified IL-7 protein. More particularly, it comprises (a) a modified IL-7 fusion protein; (b) a basal...
2018/0327471 TRANSLATABLE MOLECULES AND SYNTHESIS THEREOF
A range of therapeutic mRNA molecules expressible to provide a target polypeptide or protein. The RNA molecules can contain one or more 5-methoxyuridines and...
2018/0327470 CHIMERIC ANTIGEN RECEPTOR-MODIFIED IMMUNE EFFECTOR CELL CARRYING PD-L1 BLOCKING AGENT
Provided is a chimeric antigen receptor-modified immune effector cell carrying a procedural death ligand 1 (PD-L1) blocking agent. Also provided is a method...
2018/0327469 BIGLYCAN MUTANTS AND RELATED THERAPEUTICS AND METHODS OF USE
The present disclosure provides compositions and methods for treating diseases or conditions associated with an abnormal level or activity of biglycan;...
2018/0327468 HISTATINS AND METHOD OF USE THEREOF
Synthetic histatins composed of combinations of functional domains of natural histatins separated by exogenous linkers are described as are methods of using...
2018/0327467 PEPTIDES FOR THE TREATMENT OF RESORPTIVE BONE DISEASE
Described are methods and associated uses for the treatment of resorptive bone disease using peptides comprising all of part of the C-terminal portion of...
2018/0327466 PEPTIDES
The present invention relates to novel peptides derived from Calcium homeostasis modulator protein 3 (CALHM3), complexes comprising such peptides bound to...
2018/0327465 LIGAND-GUIDED PHAGOCYTOSIS BASED THERAPY FOR TREATMENT OF ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES
Disclosed are conjugates and compositions comprising an amyloid beta binding protein conjugated to a MerTK ligand. Disclosed are methods of clearing amyloid...
2018/0327464 COMPOSITION FOR IMPROVING SKIN CONDITIONS COMPRISING A FRAGMENT OF HUMAN HEAT SHOCK PROTEIN 90A AS AN ACTIVE...
Liposomal and/or nano-liposomal encapsulated peptides of HSP90a, HPf polypeptide (115 aa) and novel polypeptides HPf.DELTA.C1 (101 aa) and HPf.DELTA.C2 (87...
2018/0327463 Peptides
The present invention provides a peptide at least partially derivable from human Thyroid Stimulating Hormone Receptor (TSHR) which peptide is capable of...
2018/0327462 TARGETING PROTEINS FOR DEGRADATION
Embodiments provided here include recombinant polypeptides, termed degradons, comprising a target binding domain and a proteasome-binding domain. Degradons of...
2018/0327461 COMPOSITIONS AND METHODS FOR CONTROL OF VECTOR-BORNE DISEASE
This disclosure describes a genetically-modified microbe that is a symbiont of an animal that is a vector organism for a pathogenic microbe, a paratransgenic...
2018/0327460 MUTANT FRAGMENTS OF OSPA AND METHODS AND USES RELATING THERETO
The present invention relates to a polypeptide comprising a mutant fragment of an outer surface protein A (OspA), a nucleic acid coding the same, a...
2018/0327459 COMPOSITIONS AND METHODS TO PREVENT CANCER BY STABILIZING P53 THROUGH NON MDM2-MEDIATED PATHWAYS
The present invention relates to compositions and methods comprising chemopreventive agents that may be cupredoxin(s) or variants, derivatives and structural...
2018/0327458 PHARMACEUTICAL COMPOSITIONS FOR PREVENTION OR TREATMENT OF NEURODEGENERATIVE DISEASES
The present invention relates to methods and compositions for the prevention or treatment of neurodegenerative diseases.
2018/0327457 INDUSTRIALLY SCALABLE PROCESS FOR RECOVERING BIOLOGICALLY ACTIVE RECOMBINANT CARRIER PROTEINS
The present invention relates to a preparation method which is performed by expressing the recombinant carrier proteins in Escherichia coli and purification...
2018/0327456 SELENIUM-BASED THERAPIES
This invention relates to methods of administering compounds containing selenium, selenocysteine, or a selenocysteine peptide to treat, for example, conditions...
2018/0327455 CYCLIC PEPTIDOMIMETICS, COMPOSITIONS CONTAINING THEM AND THEIR USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH...
The present invention relates to novel cyclic peptidomimetics, pharmaceutical compositions containing them and their use in the treatment of diseases...
2018/0327454 PEPTIDE PHARMACEUTICALS
Described herein are methods of syntheses and therapeutic uses of covalently modified peptides and/or proteins. The covalently modified peptides and/or...
2018/0327453 HER-2-SPECIFIC CYCLIZED SUPR PEPTIDES
Disclosed are highly potent peptides, peptide conjugates, host cells and compositions containing one or more of these peptides, peptide conjugates and/or host...
2018/0327452 COMPOSITION FOR IMPROVING MEMORY, LEARNING ABILITY, AND COGNITIVE ABILITY
There is provided a composition for improving memory, learning ability, and cognitive ability. It has been confirmed that a peptide having a C-terminal region...
2018/0327451 COMPOSITION FOR IMPROVING MEMORY, LEARNING ABILITY, AND COGNITIVE ABILITY
There is provided a composition for improving memory, learning ability, and cognitive ability. It has been confirmed that a peptide having a C-terminal region...
2018/0327450 AROMATIC-CATIONIC PEPTIDES AND METHODS FOR USING SAME
The present disclosure provides methods of preventing or treating renal ischemia-reperfusion injury in a mammalian subject and methods for chronic treatment of...
2018/0327449 PRODRUG OF AN ICE INHIBITOR
This invention describes an ICE inhibitor prodrug (I) having good bioavailability. ##STR00001## Compound I is useful for treating IL-1 mediated diseases such as ...
2018/0327448 PURIFICATION METHOD, PURIFICATION KIT, AND SILICON OXIDE-BINDING TAG FOR USE THEREIN
The present invention provides a method for purifying an intended substance, a kit for purifying the intended substance, and a silicon oxide-binding tag for...
2018/0327447 IMPROVED PROTEIN SEPARATION IN ION EXCHANGE CHROMATOGRAPHY
Disclosed are improved preparative (>5 g/l) protein separations, which are achieved by combining salt and pH gradients for preparative protein separations...
2018/0327446 PURIFICATION OF FKPA AND USES THEREOF FOR PRODUCING RECOMBINANT POLYPEPTIDES
The present invention provides methods for producing FKBP-type peptidyl-prolyl cis-trans isomerase (FkpA) polypeptides at very high levels of purity. Also...
2018/0327445 METHODS AND COMPOSITIONS FOR STIMULATION OF THE INTESTINAL ENTEROENDOCRINE SYSTEM FOR TREATING DISEASES OR...
This invention relates to methods of stimulating the activity of the human and animal enteric nervous system. The method comprises orally administering an...
2018/0327444 CHEMICAL COMPOUNDS AND USE THEREOF FOR IMPROVING MUSCULAR QUALITY
Chemical compounds and the therapeutic use thereof, in particular for improving muscular quality in mammals. More particularly, a method of improving muscular...
2018/0327443 NANOPARTICLES, PROCESS FOR PREPARATION AND USE THEREOF AS CARRIER FOR AMPHIPATIC AND HYDROPHOBIC MOLECULES IN...
The present invention regards nanoparticles comprising a sterol and a component derived from Quillaja saponaria Molina selected from quillaja acid and quillaja...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.